ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,893.62
      0.39%
      US Tech 100
      20,000.80
      0.69%
      Dow Jones
      43,389.60
      -0.13%
      Brent Oil
      73.005
      3.25%
      Bitcoin
      91,320.12
      1.62%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Revolution Medicines Inc (RVMD)

      7. Revolution Medicines Inc (RVMD) Financials

      Revolution Medicines Inc

      Revolution Medicines Inc (RVMD)

      NASDAQ
      54.24
      -0.89
      (-1.61%)
      At close: November 18 4:00PM
      Delayed by 15 minutes
      54.24
      0.04
      ( 0.07% )
      After Hours: 4:20PM
      Delayed by 15 minutes

      Revolution Medicines Inc Financial Summary

      The current RVMD market cap is 9.12B. The company's latest EPS is USD -2.5940 and P/E is -0.16.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0742k000
      Operating Income -123.25M-179.98M-140.86M-156.64M-175.71M
      Net Income -108.43M-161.54M-116M-133.23M-156.29M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 50.04M42.98M29.39M35.38M11.58M
      Operating Income -54.12M-110.7M-188.01M-258.28M-487.19M
      Net Income -61.9M-110.38M-187.09M-248.71M-436.37M

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 984.23M2.06B1.91B1.81B1.76B
      Total Liabilities 146.77M235.51M182.9M189.59M196.7M
      Total Equity 837.46M1.83B1.73B1.62B1.57B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 220.53M567.4M737.99M811.93M2.06B
      Total Liabilities 67.99M92.73M135.42M126.74M235.51M
      Total Equity -152.57M474.68M602.57M685.19M1.83B

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -230.01M-350.57M-160.56M-288.73M-419.15M
      Investing 37.8M-342.6M-247.97M-140.02M-161.49M
      Financing 389.85M1.23B810k8.31M85.61M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -49.62M-100.06M-147.18M-224.4M-350.57M
      Investing -101.97M-234.23M-142.12M-24.12M-342.6M
      Financing 98.66M422.78M294.18M301.43M1.23B

      Stats and Ratios

      Market Cap 9.12B
      Price to Earnings Ratio -0.16
      Price to Sales Ratio 6.1
      Price to Cash Ratio 0.1
      Price to Book Ratio 0.04
      Dividend Yield -

      Share Statistics

      Shares Outstanding 168.22M
      Average Volume (1 week) 1.47M
      Average Volume (1 Month) 1.67M
      52 Week Change 154.17%
      52 Week High 62.40
      52 Week Low 20.51
      Spread (Intraday) 3.3 (5.73%)

      Company Info

      Company Name Revolution Medicines Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.revmed.com
      Industry biological pds,ex diagnstics (2836)